Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics.

The model nephrotoxin cyclosporin A was administered to male Wistar-derived rats daily for 9 days at a dose level of 45 mg/kg per day. Urine samples were collected daily and the excretion pattern of low molecular mass organic molecules in the urine was studied using 1H NMR spectroscopy and HPLC-TOF/MS. Distinct changes in the pattern of endogenous metabolites, as a result of the daily administration of cyclosporin A, were observed by 1H NMR from day 7 onwards. The NMR-detected markers included raised concentrations of glucose, acetate, trimethylamine and succinate and reduced amounts of trimethylamine-N-oxide. In parallel studies by HPLC-TOF/MS a reduction in the quantities of kynurenic acid, xanthurenic acid, citric acid and riboflavin present in the urines was noted, together with reductions in a number of as yet unidentified compounds. In addition, signals resulting from the polyethylene glycol, present in the dosing vehicle, and cyclosporin A metabolites were detected by MS. However, these were excluded from the subsequent multivariate data analysis in order to highlight only changes to the endogenous metabolites. Analysis of both the 1H NMR and HPLC-MS spectroscopic data using pattern recognition techniques clearly identified the onset of changes due to nephrotoxicity.

[1]  Ian D Wilson,et al.  Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): detection of strain, diurnal and gender differences. , 2003, The Analyst.

[2]  E Holmes,et al.  Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. , 2002, The Analyst.

[3]  Robert S Plumb,et al.  Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. , 2002, Rapid communications in mass spectrometry : RCM.

[4]  P J Sadler,et al.  Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. , 1989, Molecular pharmacology.

[5]  J. Sloane,et al.  Nature of the toxicity of cyclosporin A in the rat. , 1981, Biochemical pharmacology.

[6]  R. Williams,et al.  Effect of intestinal microflora on the urinary metabolic profile of rats: a 1 H-nuclear magnetic resonance spectroscopy study , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  J. Nicholson,et al.  Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  I. Wilson,et al.  Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS‐DA , 2002, FEBS letters.

[9]  Ina Schuppe-Koistinen,et al.  Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis. , 2003, Analytical chemistry.

[10]  I. Wilson,et al.  A 1H NMR spectroscopic study of the biochemical effects of ifosfamide in the rat: evaluation of potential biomarkers , 2000 .

[11]  J. Nicholson,et al.  Investigations into the biochemical effects of region-specific nephrotoxins. , 1989, Molecular pharmacology.

[12]  E Holmes,et al.  Accelerated toxicity screening using NMR and pattern recognition-based methods. , 2000, Current opinion in drug discovery & development.

[13]  I. Wilson,et al.  Nuclear magnetic resonance and high-performance liquid chromatography-nuclear magnetic resonance studies on the toxicity and metabolism of ifosfamide. , 1996, Therapeutic drug monitoring.

[14]  M. Reily,et al.  Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  I. Wilson,et al.  An NMR‐based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse , 2000, FEBS letters.

[16]  C. Waterfield,et al.  Use of urinary taurine and creatine as biomarkers of organ dysfunction and metabolic perturbations , 1995, Comparative Haematology International.

[17]  J C Lindon,et al.  Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. , 1994, Molecular pharmacology.

[18]  I. Wilson,et al.  Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[19]  E Holmes,et al.  Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. , 1998, Chemical research in toxicology.

[20]  Christophe Junot,et al.  Metabolite profiling in rat urine by liquid chromatography/electrospray ion trap mass spectrometry. Application to the study of heavy metal toxicity. , 2003, Rapid communications in mass spectrometry : RCM.